News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ImmunoGen, Inc. (IMGN) Announces Webcast of Presentations at Upcoming Investor Conferences


5/30/2013 10:17:28 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) antibody-drug conjugate (ADC) technology, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:

•Jefferies 2013 Global Healthcare Conference 11:30 am ET, June 5, 2013 in New York, NY Presenter: Daniel Junius, President and CEO

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES